Due to the synergy we observe with this combination in vitro in several melanoma cell lines, (and the apparent high BCL-2 expression in melanoma patient tissue), this could provide the most attractive avenue for future investigation of BH3-mimetics in melanoma. Here, BCL2 is linked to melanoma.